Background: Relationships between companies in the biomedical industry and authors submitting scientific articles for publication has been an issue of some concern for many years. It has been frequently demonstrated that these financial relationships can influence the manner in which research findings are presented. The National Physician Payment Transparency Program, also known as the Open Payment Program or the Sunshine Act, was legislated to expose potential conflicts of interest (COIs). Likewise, most peer-reviewed journals require disclosure of any potential COIs. Objectives: The purpose of this paper was to compare the information published in the Open Payment Database to authors' self-disclosed COIs in their published articles. Methods: An analysis was performed by one of the authors (P.S.B.) of all articles published in Aesthetic Surgery Journal (ASJ) and Plastic and Reconstructive Surgery (PRS) from August 2013 through December 2016. Financial disclosures reported in these articles were compared with the physician payment information provided by the biomedical industry and published in the Open Payments Database in 2013 and 2018. Results: A total of 1346 articles were included in the study, from which 320 authors and 899 total authorships were eligible for analysis. Out of 782 authorships with noted discrepancies, 96% were related to potential COIs found in the Open Payments database but not disclosed in the journal publication. Conclusions: Our data suggest major discordance between authors' self-reported COIs in the plastic surgery literature and industry payments published in the Open Payments database.
A significant dialog regarding bias in medical research has emerged in recent years, 1 including in the ever-evolving field of plastic surgery. [2] [3] [4] Bias in the context of research is any propensity that precludes unprejudiced evaluation of a study. 5 Understanding bias and how it affects study results is crucial for physicians to critically analyze scientific literature and make informed decisions as to the accuracy of the contents, and the conclusions drawn from the reported data.
One major source of bias in biomedical research is that of financial conflict of interest (COI). Although collaboration with industry plays an important role in plastic surgery, this relationship has the potential to adversely affect clinical practice and patient care if not carefully monitored. A large body of literature from other specialties supports the association between industry financial support and the publication of positive findings. [6] [7] [8] [9] [10] [11] Plastic surgery is certainly not immune to this effect; articles authored by individuals with COIs are more likely to report positive outcomes 12 and lower surgical complications 13 than those authored by persons without such conflicts.
Disclosure of financial support from industry is essential for readers to make an accurate assessment of the degree to which COIs may influence the results. Although full disclosure of COIs is mandated by nearly all scientific journals, 14 until recently there was no way to determine the accuracy of these declarations.
Significant concern regarding COIs prompted lawmakers to create the Open Payments program for maintaining ethical standards in biomedical research. Implementation of the Open Payments program (Sunshine Act) by the Centers for Medicare & Medicaid Services (CMS) in 2013 required that manufacturers and group purchasing organizations report their financial relationships with physicians and hospitals. 15, 16 Under this law, the biomedical industry is obligated to report any payment over $100 annually for meals, travel, consulting fees, research support, or royalties. This information is collected continuously and made publically available in the Open Payments database. 17 Despite efforts to improve transparency, research to date has revealed inconsistencies between physician disclosures and financial information published in the Open Payments database. 18 One potential issue is that most journals have no consistent verification process for self-reported COIs, and thus rely heavily on authors to determine appropriate disclosure. 2 The aim of this study was to assess the concordance between financial COIs reported in the plastic surgery literature and the Open Payments Database.
METHODS
This study was determined to be exempt from institutional review board scrutiny, which is not required for research involving the collection and/or study of existing data, documents, or records if these sources are publicly available. An analysis of all articles published in Aesthetic Surgery Journal (ASJ) and Plastic and Reconstructive Surgery (PRS) and from August 2013 to December 2016 was conducted by a single author (P.S.B.) in January 2018. These data are available online as Appendices A and B. It was determined that these two journals, because of their wide distribution and high impact factors, would provide the greatest number of articles in which to look for potential COIs. Archived articles in ASJ and PRS were systematically reviewed in chronological order. Commentaries, Replies, Letters to the Editor, Viewpoints, and Editorials were excluded from the analysis. For each article, the title, date, journal, and category of plastic surgery research were tabulated in a spreadsheet. All US authors were given a journal ID number corresponding to the article from which they were included, along with each author's respective self-disclosed COI(s).
The spreadsheet data were formatted for clarity (ie, multiple names or spellings for the same individual or company were consolidated). This information was then merged with the 2013-2016 "General Payments" data from the Open Payments database to determine the accuracy and completeness of each author's financial disclosure(s). The previous 3 years of payments from the Open Payments data were checked relative to the publication year from the collected data. For example, if an author published and disclosed something in 2015, the database was searched for discrepancies in the 2013 and 2014 Open Payments data as well.
Inclusion criteria for analysis were authors who had "Plastic" in the "Specialties" field text from the Open Payments data, and "MD" or "M.D." in the author name text field from the original collected data. Additionally, only disclosures from the Open Payments data that were $250 or more in value were analyzed. The list of companies was systematically compared against the Open Payments database for disclosures found in the database but not cited by the author, and vice versa. Any discrepancies between payments data were flagged for further analysis.
RESULTS
A total of 4112 articles were reviewed, with 1346 eligible for analysis based on the inclusion criteria. Out of these eligible articles, 1114 (83%) came from PRS, and 232 (17%) from ASJ. There were a total of 3677 authors in the collected data, with 3357 excluded from the analysis for the following reasons: non-MD author (n = 1231), non-plastic surgeon MD (n = 896), no profile in the Open Payments database (n = 904), and disclosures totaling less than $250 (n = 326). Based on these criteria, in total 320 authors were included in the analysis. Of these authors, 278 (87%) had at least one discrepancy between payment data in the database vs their publication.
There were 899 total authorships from the eligible authors, with 782 (87%) having some form of discrepancy (Table 1) . From these authorships, 1354 total discrepancies The results also demonstrated that author position was predictive of having at least one payment discrepancy (P = 0.07). According to the data, a middle author is less likely to have discrepancies than the first or last author (odds ratio: 3.593; 95% confidence interval: 1.211, 10.657; P = 0.0212). There was no significant difference between first author and last authors with regard to discrepancies.
DISCUSSION
The Open Payments database was implemented with the goal of increased awareness and transparency regarding physician payments from the biomedical industry. This study sought to determine the accuracy of self-reported COIs in the plastic surgery literature when compared against the Open Payments database. Most authorships examined exhibited a degree of inconsistent disclosure information. Further, nearly all of these discrepancies were a result of financial payments revealed in the database but not reported in publications. Our results also demonstrated that the majority of authors with $250 or more in payments had at least one monetary discrepancy. However, there was no significant relationship between the total amount of payment and discrepancy. Although the data seem to suggest a serious issue with self-reported COIs in the plastic surgery literature, it does not suggest nefarious intent from study authors as being the root of this problem.
COI has become an important issue in research for many diverse medical specialties. Recent studies demonstrate substantial discrepancies between self-reported COIs and published payment data. [19] [20] [21] [22] One such article found an overall discordance rate of 65% in the literature from all surgical specialties examined in the study. 21 Interestingly, our findings suggest an even higher rate of disclosure inconsistencies in plastic surgery research.
Federal funding of research has declined over the past decade, with increased collaboration occurring between physicians and for-profit medical companies. 23 Recent estimates indicate that pharmaceutical and device manufacturers fund nearly two-thirds of medical research in the United States. 24 According to the 2015 Open Payments data, healthcare industry manufacturers reported over $7.5 billion in financial relationships with physicians and hospitals. 25 Collaboration with the biomedical industry undoubtedly plays a significant role in advancing the rapidly growing field of plastic surgery. However, the quality of research supported by industry must be carefully scrutinized to avoid reporting bias.
Studies must be rigorously designed, conducted, and honestly reported by investigators irrespective of funding sources in order to minimize research bias. Despite a gradual trend toward higher-level study designs over the years, the rate of change has been slow, and published research in plastic surgery frequently demonstrates poor methodologic quality. 26 Research methods, how they are applied, and how results are reported can be influenced by bias, especially in the context of financial relationships. Regardless of funding source, vigilance in study design and disclosure reporting can help ensure the quality of evidence put forth in the plastic surgery literature.
The review process for published research presents an opportunity to improve transparency of financial interests. The current system lacks standardized guidelines for authors on what constitutes a potential COI that should be disclosed. One very common reason for nondisclosure is the assumption that a financial relationship is unrelated to the topic of the article. 27 Instead of dishonest intent, there is most likely a general confusion regarding appropriate disclosure protocol and inconsistency in reporting. Both the American Society of Plastic Surgeons (ASPS) and the American Society for Aesthetic Plastic Surgery (ASAPS) have revised their COI polices in recent years. 28, 29 The ASPS sets $100 as the starting amount of what needs to be reported, and the ASAPS defined the timeframe of what must be disclosed to include the current month and the preceding 12 months. Using these documents as a guideline, a potential solution to this issue for all of our specialty journals may be to set both a specific dollar amount on payments that must be reported in each publication, and a timeframe, rather than the author trying to determine what amount constitutes a COI. Other potential solutions may include random verification checks or requirements for authors to list all income from any medical and pharmaceutical companies in their disclosure statement, regardless of perceived relevance to the article. Conversely, it would be helpful if companies were required to notify individuals that they have reported as having received a payment from them. This simple addition to the process would serve both to alert the physician as well as to enable him or her to correct any misinformation.
Despite the nearly universal requirement of full COI disclosure in peer-reviewed journals, physicians are not required to report their financial relationships to CMS. All information published by the Open Payments database comes directly from biomedical companies' reporting.
Some predict that public exposure of industry payments to physicians may unintentionally reduce these financial relationships. 30 Interestingly, the 2015 payments report showed a significant increase in charitable contributions and a decrease in gifts/honoraria paid to doctors. 30 The current data suggest that as the Open Payments database is still in its infancy, future studies may elucidate important trends in physician payments.
Although not required by law, it behooves physicians to take an active role in their CMS report to ensure accuracy. Many physicians are disconcerted at the prospect of having their financial relationships with industry publically scrutinized, because these may be perceived as "bribes." 31 However, there are ways to mitigate this effect. Surgeons have been advised to keep track of their payments, review their CMS report regularly, and maintain a forthcoming attitude regarding their financial relationships. 31 In addition, both the American Medical Association and the CMS have released resources to aid in navigating the reporting process and handling patient inquiries on the Open Payments Database. 32, 33 By embracing this change rather than trying to avoid it, plastic surgeons can help maintain transparency and the high ethical standards of this specialty.
Many aspects of the Sunshine Act remain confusing both to the physician and to the companies providing payment information. In one study physicians were less likely to consider such items as food, travel, and lodging as a reportable COI and more likely to report such items as royalties, consultancies, or ownership in the company. 34 The payment system is further compounded by much minutia, such as the company must report a per capita expense for a provided meal, but only if the registrant actually consumes the food! There are limitations to the database and this article. All applicable manufacturers (ie, those operating, or conducting activities, in the United States) and applicable group purchasing organizations are required to report payments made to physicians and teaching hospitals. There are exclusions including existing personal relationships, payments less than $10, educational materials that directly benefit patients, in-kind items for the provision of charity care, product samples, short-term loan of a device, contractual warranty, covered recipient acting as a patient, provision of healthcare, nonmedical professional, a dividend or other profit distribution from a publicly traded security or mutual fund, civil or criminal action, and indirect payments where the manufacturer is unaware of the identity of the recipient and drug samples.
CONCLUSION
This study finds that there is a notable discordance between financial information published in the physician payment database and self-reported COIs. For plastic surgeons who published in either the ASJ or PRS between 2013 and 2016 with more than $250 in payments from industry, the vast majority (87%) had at least one discrepancy between self-reported COIs and the data from the Open Payments Database.
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